Download PDF
The Journal of Hip Surgery 2023; 07(01): 043-050
DOI: 10.1055/s-0043-1764440
Original Article

Trends in Opioid Use Following Primary Total Hip Arthroplasty from 2016 to 2021: Have Improved Postoperative Opioid Protocols Decreased Usage?

Christopher M. Scanlon
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Thomas H Christensen
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Thomas Bieganowski
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Vinaya Rajahraman 
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Ran Schwarzkopf
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Roy I Davidovitch
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Several studies have proposed protocols aimed at limiting the use of opioids following orthopedic surgery. However, current literature has not described the changing trends in opioid use over time. Therefore, the purpose of the present analysis was to determine how opioid use has changed following primary total hip arthroplasty (THA) within the last 5 years.We retrospectively reviewed all patients who underwent primary THA at our institution between January 2016 and April 2021 with a minimum length of stay of one midnight. Demographic data including age, gender, race, body mass index, American Society of Anesthesiologist classification as well as dosage and type of opioid medication prescribed on each postoperative day while in the hospital were collected. These data were converted to milligram morphine equivalents (MME) per day of hospitalization to facilitate comparison. Linear regression analysis was used to detect the significance of yearly trends in MME per day.We identified 7,897 patients who met inclusion and exclusion criteria. The greatest daily average opioid usage per patient was in 2016 (34.5 ± 77.5 MME/d) and the least was in 2021 (13.3 ± 16.5 MME/d). Our analysis demonstrated a significant linear downward trend in average daily postoperative opioid usage over time with an average decrease of 2.81 MME/d each year (R 2: 0.004; p< 0.001). Concerns regarding the negative effects of opioid pain medication following orthopedic surgery have encouraged the development of opioid-reducing protocols. The results of this analysis demonstrate the successful impact of these efforts on limiting opioid consumption during the hospital stay following primary THA. This is a level III evidence retrospective cohort study.

Keywords

total hip arthroplasty - opioid use - pain management - postoperative pain


Publication History

Received: 22 August 2022

Accepted: 29 December 2022

Article published online:
16 March 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Madras BK. The President's Commission on Combating Drug Addiction and the opioid crisis: origins and recommendations. Clin PharmacolTher 2018; 103 (06) 943-945
    PubMedGoogle Scholar
  • 2 Wainwright JJ, Mikre M, Whitley P. et al. Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak. JAMA 2020; 324 (16) 1674-1677
    CrossrefPubMedGoogle Scholar
  • 3 Ochalek TA, Cumpston KL, Wills BK, Gal TS, Moeller FG. Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic. JAMA 2020; 324 (16) 1673-1674
    CrossrefPubMedGoogle Scholar
  • 4 Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths---United States, 2013-2017. MMWR Morb Mortal Wkly Rep 2018; 67 (5152): 1419-1427
    CrossrefPubMedGoogle Scholar
  • 5 Brat GA, Agniel D, Beam A. et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ 2018; 360: j5790
    CrossrefPubMedGoogle Scholar
  • 6 Shah A, Hayes CJ, Martin BC. Factors influencing long-term opioid use among opioid naive patients: an examination of initial prescription characteristics and pain etiologies. J Pain 2017; 18 (11) 1374-1383
    CrossrefPubMedGoogle Scholar
  • 7 Tan TL, Rondon AJ, Wilt Z. et al. Understanding opioid use after total hip arthroplasty: a comprehensive analysis of a mandatory prescription drug monitoring program. J Am AcadOrthop Surg 2020; 28 (20) e917-e922
    CrossrefPubMedGoogle Scholar
  • 8 Opioid Use, Misuse, and Abuse in Orthopaedic Practice. Published 2015. Accessed May 23, 2022 at: https://aaos.org/globalassets/about/bylaws-library/information-statements/1045-opioid-use-misuse-and-abuse-in-practice.pdf
    PubMed
  • 9 Bicket M, White E, Wu C, Pronovost P, Yaster M, Alexander G. (232) Prescription opioid oversupply following orthopedic surgery: a prospective cohort study. J Pain 2017; 18 (04) S34
    CrossrefPubMedGoogle Scholar
  • 10 Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med 2011; 12 (05) 747-754
    CrossrefPubMedGoogle Scholar
  • 11 Reid DBC, Shapiro B, Shah KN. et al. Has a prescription-limiting law in Rhode Island helped to reduce opioid use after total joint arthroplasty?. Clin OrthopRelat Res 2020; 478 (02) 205-215
    CrossrefPubMedGoogle Scholar
  • 12 Archambault S, Lombardi F, Prata E, McCaffrey M, Metts H. . Chapter 21–28 Uniform Controlled Substances Act. 2015
  • 13 Golladay GJ, Balch KR, Dalury DF, Satpathy J, Jiranek WA. Oral multimodal analgesia for total joint arthroplasty. J Arthroplasty 2017; 32 9S S69-S73
    CrossrefPubMedGoogle Scholar
  • 14 Karam JA, Schwenk ES, Parvizi J. An update on multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am 2021; 103 (17) 1652-1662
    CrossrefPubMedGoogle Scholar
  • 15 Simpson JC, Bao X, Agarwala A. Pain management in enhanced recovery after surgery (ERAS) protocols. Clin Colon Rectal Surg 2019; 32 (02) 121-128
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Thompson-Brazill KA. Pain control in the cardiothoracic surgery patient. Crit Care Nurs Clin North Am 2019; 31 (03) 389-405
    CrossrefPubMedGoogle Scholar
  • 17 Yoo JS, Ahn J, Buvanendran A, Singh K. Multimodal analgesia in pain management after spine surgery. J Spine Surg 2019; 5 (Suppl (Suppl. 02) S154-S159
    CrossrefPubMedGoogle Scholar
  • 18 Frkovich J, Hedrick H, Anakaraonye AR, Bornkessel A, Lefebvre RC. Opioid-related public health communication campaigns: an environmental scan. Am J Health Promot 2022; 36 (06) 913-919
    CrossrefPubMedGoogle Scholar
  • 19 CDC compilation of benzodiazepines, muscle relaxants, stimulants, zolpidem, and opioid analgesics with oral morphine milligram equivalent conversion factors. Published 2017. Accessed May 24, 2022. https://www.cdc.gov/opioids/data-resources/index.html
    PubMed
  • 20 Feng JE, Mahure SA, Waren DP. et al. Utilization of a novel opioid-sparing protocol in primary total hip arthroplasty results in reduced opiate consumption and improved functional status. J Arthroplasty 2020; 35 6S S231-S236
    CrossrefPubMedGoogle Scholar
  • 21 Feng JE, Ikwuazom CP, Slover JD, Macaulay W, Schwarzkopf R, Long WJ. Discontinuation of intraoperative liposomal bupivacaine in primary THA does not clinically change postoperative subjective pain, opioid consumption, or objective functional status. J Arthroplasty 2021; 36 (06) 2062-2067
    CrossrefPubMedGoogle Scholar
  • 22 Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 2011; 63 (Suppl (Suppl. 11) S240-S252
    CrossrefPubMedGoogle Scholar
  • 23 Bonica JJ. . The Management of Pain. 2nd ed. Lea &Febiger; 1990.
  • 24 Parvizi J, Miller AG, Gandhi K. Multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am 2011; 93 (11) 1075-1084
    CrossrefPubMedGoogle Scholar
  • 25 Halawi MJ, Grant SA, Bolognesi MP. Multimodal analgesia for total joint arthroplasty. Orthopedics 2015; 38 (07) e616-e625
    CrossrefPubMedGoogle Scholar
  • 26 Pepper AM, Mercuri JJ, Behery OA, Vigdorchik JM. Total hip and knee arthroplasty perioperative pain management: what should be in the cocktail. JBJS Rev 2018; 6 (12) e5-e5
    CrossrefPubMedGoogle Scholar
  • 27 Prentice HA, Inacio MCS, Singh A, Namba RS, Paxton EW. Preoperative risk factors for opioid utilization after total hip arthroplasty. J Bone Joint Surg Am 2019; 101 (18) 1670-1678
    CrossrefPubMedGoogle Scholar
  • 28 Larach DB, Sahara MJ, As-Sanie S. et al. Patient factors associated with opioid consumption in the month following major surgery. Ann Surg 2021; 273 (03) 507-515
    CrossrefPubMedGoogle Scholar
  • 29 Mehta BY, Bass AR, Goto R. et al. Disparities in outcomes for blacks versus whites undergoing total hip arthroplasty: a systematic literature review. J Rheumatol 2018; 45 (05) 717-722
    CrossrefPubMedGoogle Scholar
  • 30 Maratt JD, Lee YY, Lyman S, Westrich GH. Predictors of satisfaction following total knee arthroplasty. J Arthroplasty 2015; 30 (07) 1142-1145
    CrossrefPubMedGoogle Scholar
  • 31 Jacobs CA, Christensen CP, Karthikeyan T. Patient and intraoperative factors influencing satisfaction two to five years after primary total knee arthroplasty. J Arthroplasty 2014; 29 (08) 1576-1579
    CrossrefPubMedGoogle Scholar
  • 32 Hu S, Zhang ZY, Hua YQ, Li J, Cai ZD. A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis. J Bone Joint Surg Br 2009; 91 (07) 935-942
    CrossrefPubMedGoogle Scholar
  • 33 Guay J. The effect of neuraxial blocks on surgical blood loss and blood transfusion requirements: a meta-analysis. J ClinAnesth 2006; 18 (02) 124-128
    PubMedGoogle Scholar
  • 34 Fan ZR, Ma J, Ma XL. et al. The efficacy of dexamethasone on pain and recovery after total hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2018; 97 (13) e0100
    CrossrefPubMedGoogle Scholar
  • 35 Shin HJ, Do SH, Lee JS, Kim TK, Na HS. Comparison of intraoperative sedation with dexmedetomidine versus propofol on acute postoperative pain in total knee arthroplasty under spinal anesthesia: a randomized trial. AnesthAnalg 2019; 129 (06) 1512-1518
    PubMedGoogle Scholar
  • 36 Roebke AJ, Via GG, Everhart JS. et al. Inpatient and outpatient opioid requirements after total joint replacement are strongly influenced by patient and surgical factors. Bone Jt Open 2020; 1 (07) 398-404
    CrossrefPubMedGoogle Scholar